Quick Answer
Clearside Biomedical, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $1.66 million for the year ending 2024.
- Clearside Biomedical, Inc. showed a decrease of -79.8% in Revenue From Contract With Customer Excluding Assessed Tax from 2023 to 2024.
- This data is from Clearside Biomedical, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2025.
- XBRL data for this metric is available from 2016 to 2024 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2016 to 2024), Clearside Biomedical, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 220.0%.
- Historical annual values: Fiscal year 2024: $1.66 million | Fiscal year 2023: $8.23 million | Fiscal year 2022: $1.33 million | Fiscal year 2021: $29.58 million | Fiscal year 2020: $7.89 million | Fiscal year 2019: $2.17 million | Fiscal year 2018: $30.0 thousand | Fiscal year 2017: $345.0 thousand | Fiscal year 2016: $520.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: